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The binding of lipid and peptide chemotactic factors to cell surface receptors 
on  polymorphonuclear  leukocytes  (PMNL) l  initiates  a  series  of intracellular 
biochemical events that lead to increased chemokinetic and chemotactic migra- 
tion, aggregation, adherence, lysosomal degranulation, and production of super- 
oxide anion (1-3). The rapid stimulation, by chemotactic factors, of phospholipid 
and protein  methylation  (4-6),  arachidonic  acid release (4,  5,  7),  phosphatidyl 
inositol  turnover  (8-10),  internal  calcium  release  and  influx  of extracellular 
calcium (1 1,  12), glucose flux (13), and membrane depolarization  (14) suggests 
that  these events are closely coupled to receptor occupancy, yet little is known 
about the transductional process. 
Modulation by guanine nucleotides of the affinity of receptors for N-formyl- 
methionyl peptides in membranes of human  PMNL (15), and the activation, by 
N-formyl-methionyl-leucyl-phenylalanine  (fMLP),  of a  GTPase  activity  in  ho- 
mogenates of PMNL (16) suggested that a  guanine  nucleotide-binding protein 
may participate in the transduction of signals from occupied receptors. Hormon- 
ally stimulated  activation  and  inhibition  of adenylate  cyclase are  mediated  by 
coupling proteins,  termed  Gs and  Gi,  respectively, which  have  similar  subunit 
structures  and  amino  acid  compositions  (17);  the  a  subunit  of each  protein 
contains  a  guanine  nucleotide-binding  site.  Cholera  toxin-induced  ADP-ribo- 
sylation  of the  o~ subunit  of Gs stabilizes  Gs in  the  active  state,  and  results  in 
persistent activation of adenylate cyclase (18-20). A bacterial toxin isolated from 
Bordetella pertussis  similarly  catalyzes ADP-ribosylation of the a  subunit of Gi, 
and,  consequently, attenuates hormonal  inhibition  of adenylate cyclase activity 
(18,  19, 21). Although pertussis toxin treatment of rat mast cells does not alter 
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cyclic AMP (cAMP)  levels (22),  it blocks ligand-stimulated  release of histamine 
(23).  That  pertussis  toxin  might  be  acting  on  a  GTP-binding  protein  was 
suggested by the capacity of stable analogs of GTP to promote histamine release 
(23-25).  To determine whether a pertussis toxin-sensitive GTP-binding protein 
is involved in the coupling of PMNL chemotactic factor receptors to functional 
activation, we assessed the effects of pertussis toxin on binding of leukotriene B4 
(LTB4) to human  PMNL and on chemotactic factor-induced increases in cyto- 
solic calcium concentration, chemotactic migration, and degranulation. 
Materials and  Methods 
Materials.  Hank's balanced salt solution  without  phenol  red  (HBSS) (University of 
California Cell Culture Facility, San Francisco, CA), diisopropylfluorophosphate (DFP), 
fMLP,  n-butyl  phthalate,  4-/3-phorbol-12-myristate-13-acetate (PMA),  phenoiphthalein 
glucuronic acid,  human  albumin,  lyophilized Micrococcus lysodeikticus (Sigma Chemical 
Co.,  St.  Louis,  MO),  ovalbumin (OVA) (Miles Laboratories,  Inc., Elkhart,  IN), Ficoll- 
Paque, 6% (wt/vol) dextran 70 in normal saline (Pharmacia Fine Chemicals, Piscataway, 
N J),  a-[3~P]-NAD (New England  Nuclear,  Boston, MA),  5,  6,  8,  9,  1 I,  12,  14,  15  (N)- 
[3H]-LTB4  (209  Ci/mmole),  Quin  2/AM  (Amersham  Corp.,  Arlington  Heights,  IL), 
A23187  (Calbiochem-Behring,  La Jolla,  CA),  cytochalasin  B  (Aldrich  Chemical  Co., 
Milwaukee, WI), Hydrofluor scintillation fluid (National Diagnostics, Inc., Somerville, NJ) 
and  gel  electrophoresis  reagents  (Bio-Rad,  Richmond,  CA)  were  obtained  from  the 
suppliers noted.  Partially purified chc  lotactic  fragments of C5  (C5fr)  were  prepared 
from yeast-activated human serum, as described (26). Synthetic LTB4 was kindly supplied 
by J. Rokach of Merck Frosst Laboratories, Dorval, Canada. Purified pertussis toxin (27) 
was a  gift from  R.  D.  Sekura  of the  National  Institute  of Child  Health and  Human 
Development, Bethesda, MD. 
Preparation  of Human PMNL and Treatment with Pertussis Toxin.  Human PMNL were 
prepared as described (28) from sodium citrate-anticoagulated venous blood of normal 
donors. Erythrocytes were removed by dextran sedimentation, followed by a 20-s hypo- 
tonic lysis in 20 vol of ice-cold distilled water.  Isotonicity was restored by adding 0.6 M 
KC1. PMNL  of >~96% purity were obtained by centrifugation of mixed leukocytes on 
FicolI-Paque cushions (29).  The purified PMNL were suspended at 2  ×  107 cells/ml in 
HBSS containing 0.1% (wt/vol) OVA and 10 mM Hepes (pH 7.3) (HBSS-OVA). 
2 ×  10 v PMNL/ml of HBSS-OVA were incubated at 37°C with different concentrations 
of pertussis toxin  for 2  h.  Quin  2-containing PMNL were prepared by adding  20 #M 
diacetometboxyester of Quin  2  15 min before the end of incubation. The PMNL were 
then washed several times and resuspended in HBSS-OVA. Control PMNL were incubated 
for 2 h at 37°C without any additions. 
Measurement  of Quin  2 Fluorescence.  Chemotactic factor-induced changes in Quin  2 
fluorescence,  a  measure  of changes  in  the  cytosolic  calcium  concentration  (30),  was 
determined as previously described (31).  107  PMNL were suspended  in  2  ml of fresh 
HBSS-OVA and incubated at 37°C in the dark for 15 min. The fluorescence signal was 
then  recorded  with  a  Perkin-Elmer  model  640-40  spectrofluorimeter  (Perkin-EImer, 
Mountain  View,  CA)  equipped  with  a  magnetic  stirrer  and  a  water-jacketed  cuvette 
holder. The monochromators were set at 339 nm for excitation and 492 nm for emission. 
The maximum and  minimum fluorescence signals were determined  for each  batch of 
PMNL after the addition of 20 ~1 of 1% (wt/vol) Triton X-100, followed by 40 ~l of 0.5 
M Tris and 0.5 M EGTA (pH 10). The autofluorescence from an equal number of PMNL 
without Quin 2 was subtracted from the Quin 2 fluorescence values. The corrected values 
were used to calculate the intracellular Ca  +2 concentration, as described (30). 
Measurement of[3H]LTB4 binding to PMNL.  Replicate suspensions of 107 PMNL were 
incubated with 5 ×  10  -14 mol [~H]LTB4 and different concentrations of nonradioactive 
LTB4 in  a  final volume of 0.5  ml for 40  rain  in  an  ice-water bath.  The PMNL were 
centrifuged through a phthalate-oil cushion, and the amounts of bound and free LTB4 GOLDMAN  ET AL.  147 
were fit to either a one-site or two-site binding model by a method of weighted nonlinear 
least squares based on the LIGAND program (32) adapted for use on a Hewlett-Packard 
model 86B personal computer (Hewlett-Packard, Inc., Palo Alto, CA) (33). 
Measurement  of Chemotactic Migration  and Degranulation.  Chemotactic migration was 
performed in  modified Boyden chambers (Adaps,  Inc.,  Dedham,  MA) assembled with 
micropore  filters  of 3  um  pore  diameter  (Sartorius,  Gottingen,  Federal  Republic  of 
Germany) (28, 33). PMNL were counted in 10 high-power microscope fields (hpf), 5 from 
each of duplicate filters, at a depth of 80-100 #m from the cel} source. The response is 
expressed as  net  PMNL/hpf,  after subtraction  of background  migration of PMNL  in 
control  chambers  lacking  a  stimulus.  The  altered  chemotactic  migration  of  PMNL 
pretreated with pertussis toxin is expressed as a percentage of the migration of replicate 
suspensions of PMNL preincubated in HBSS-OVA alone. 
The stimulation of release of/3-glucuronidase and lysozyme from PMNL was deter- 
mined in HBSS-OVA containing 5 ug/ml of cytochalasin B. Each supernatant was assayed 
colorimetrically for/3-glucuronidase,  as described (26),  and for lysozyme by measuring 
the rate of digestion of Micrococcus lysodeikticus, and the resultant decrease in turbidity of 
the suspension (34).  The amount of enzyme release is expressed as a percentage of the 
total amount of activity present in replicate suspensions of PMNL that had been disrupted 
by sonication on ice. The percentage of enzyme released in the absence of a stimulus was 
subtracted to determine the net percentage release• The altered release of enzymes by 
PMNL  pretreated  with  pertussis toxin  is  presented  as a  percentage of the  release by 
PMNL  preincubated  in  HBSS-OVA alone.  In separate  experiments,  the simultaneous 
addition to PMNL of 100 ng/ml of pertussis toxin and a stimulus had no effect on the 
amount of/3-glucuronidase and lysozyme released by the stimulus alone, and the presence 
of up to  100  ng/ml of pertussis toxin with  the respective substrates failed to alter the 
expression of activity of either enzyme. 
Pertussis Toxin Catalyzed ADP-ribosylation of PMNL Homogenates.  PMNL were treated 
with 10  -4 M DFP in HBSS without calcium and magnesium at 37°C for 30 min (35). The 
PMNL were washed several times, resuspended at 108 cells/ml in ice cold 0.1  M sucrose 
containing  2  mM  EDTA  and  5  mM  Tris-HCl  (pH  7.2),  and  disrupted  in  a  Dounce 
homogenizer with  120 strokes at 4°C. The homogenate was centrifuged at 800 g for 10 
min at 4°C and the supernatants were stored at -70°C. 
Pertussis toxin-catalyzed ADP-ribosylation of aliquots from the 800 g supernatants was 
•  "  32  performed in 0.I M sucrose containing  10 ~M c~-[  P]NAD, 2.5 mM MgCl2,  1 mM ATP, 
10  mM  thymidine,  1  mM  dithiothreitol,  and  5  mM  Tris-HCl (pH  7.2),  as previously 
described (19,  36).  The reaction  was terminated by the addition  of 5  vol of Laemmli 
sample buffer (37). Protein was precipitated with 20% (wt/vol) of trichloroacetic acid, and 
the pellet was washed with anhydrous diethyl ether. The protein pellet was resuspended 
in  Laemmli sample buffer, and analyzed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) (37).  To quantitate incorporation of [32p] into the 41  kilo- 
dalton  (kD)  protein,  the  band  was  cut  from dried  gels and  counted  in  a  scintillation 
counter. 
Results 
Effects of Pertussis Toxin on Cytosolic  Calcium.  Quin 2-containing PMNL were 
used to monitor changes in  the  cytosolic concentration  of intracellular calcium 
([Ca+2]in). Concentrations of LTB4 and fMLP > 1 and 10 nM, respectively, elicited 
a  maximal increase of 1.8-2.5-fold  in  [Ca+2]in,  from a  resting value of 69-145 
nM to a  peak value of 150-351  nM (range, n  =  12) within 0.6-1.5  rain (Fig.  1). 
Pretreatment of PMNL with  100 ng/ml of pertussis toxin for 2  h  inhibited  the 
LTB4- and fMLP-induced  increases in [Ca+2]i~, by 98 +  2% (mean +  SD; n  =  4) 
without altering the baseline value for [Ca+2]i,, (Fig.  1).  The inhibition of LTB4- 
induced changes in [Ca+2]in by pertussis toxin was concentration-dependent  with 
half-maximal inhibition occurring at a concentration of 30 ng/ml pertussis toxin. 148  INHIBITION  OF  PMNL  FUNCTION  BY  PERTUSSIS  TOXIN 
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FIGURE  1.  Pertussis toxin inhibition of the chemotactic factor-induced increase in [Ca2+]in 
in human PMNL. The fluorescent signal from Quin 2-containing control PMNL was recorded 
for 3 rain before and 10 min after the addition of either 10 nM LTB4 or 100 nM fMLP. The 
fluorescent signal from Quin  2-containing PMNL  that had been treated with  100  ng/ml 
pertussis toxin was recorded for 3 rain before and 3 rain after the addition of LTB4,  then 100 
nM fMLP was added, and the fluorescent signal was recorded for an additional 3 min. 
In initial  studies designed to assess the time course of pertussis toxin inhibition 
of the effects of LTB4 on [Ca+2]i.,  PMNL were pretreated  with pertussis toxin 
for 30 and 90 rain before washing and adding  10  -7 M  LTB4. Pertussis toxin at 
100,  300,  and  1,000  ng/ml  inhibited  LTB4-induced  increases  in  [Ca+2]i,  by 
means of 5%, 6%, and 4% at 30 min, and 58%, 82%, and 80% at 90 min. A lag 
time of 30-60 min has also been observed for the effects of pertussis toxin on 
rat mast cells (22), pancreatic islet cells (38), and 3T3 cells (39), and is presumed 
to be required for binding of pertussis toxin and transport of the active subunit 
to the intracellular site of action (40). Pertussis toxin suppressed the increase in 
[Ca+~]i. at concentrations  of LTB4 up to 3  ×  10 -7 M, indicating  that  the toxin 
inhibits  the  increase  in  [Ca+2]in  stimulated  by both  the  high-affinity  and  low- 
affinity subsets of LTB4 receptors. 
Effect  of Pertussis  Toxin  on  Chemotaxis  and  Enzyme  Release.  The  effects of 
pertussis  toxin  on  chemotactic  migration  and  lysosomal enzyme  release  were 
assessed to examine the possible role of increases in [Ca+2]i n in the activation of 
PMNL.  Chemotaxis  elicited by LTB4,  C5fr,  and  fMLP, and  the  release of/3- 
glucuronidase elicited by LTB4 and fMLP in the presence of cytochalasin B were GOLDMAN  ET AL.  149 
inhibited by pertussis toxin with a concentration-dependence similar to that for 
inhibition of chemotactic factor-induced changes in [Ca+2]in (Figs.  2 and 3). Net 
release of 12.4 +  0.2% and 27.5  +  4.8% (mean _+ SD; n =  3) of lysozyme from 
control PMNL was elicited by 10 nM LTB4 and 1 #M fMLP, respectively. The 
release of lysozyme by the two chemotactic factors was decreased by means of 
88.7% and 87.6%, respectively, after pretreatment with  100 ng/ml of pertussis 
toxin.  The  inhibition  by  pertussis  toxin  was  specific  for  chemotactic factor- 
induced release of lysosomal enzyme. Neither the release of/3-glucuronidase 
evoked  by  the  calcium  ionophore  A23187  or  by  PMA,  which  stimulates  a 
secretory response  without  raising  [Ca+2]in (41),  was  significantly affected by 
pertussis toxin  (Fig.  3).  Lysozyme secretion elicited from PMNL  treated with 
100 ng/ml of pertussis toxin was 91.1%  and 78.6%  of the release elicited from 
control PMNL in response to PMA and A23187, respectively. 
Effect  of Pertussis  Toxin  on LTB4 Receptors.  Incubation  of PMNL  with  100 
ng/ml pertussis toxin significantly reduced the number of high-affinity receptors 
for LTB4  by a  mean of 61%  on  PMNL,  and consistently induced a  threefold 
increase in  their affinity for  LTB4,  without  affecting the number or  agonist 
affinity of the low-affinity LTB4 receptors (Table I). This suggests that pertussis 
toxin acts at a step in the signal transduction process that is closely linked to the 
LTB4 receptor. 
ADP-ribosylation  of PMNL Homogenates.  Preactivated pertussis  toxin specifi- 
cally catalyzes the transfer of [32p]-labeled ADP-ribose from [32p]NAD to a  41 
kD protein in  PMNL  homogenates (Fig.  4).  The protein comigrates on  SDS- 
PAGE  with  the  ADP-ribosylated  a  subunit  of  Gi  from  human  erythrocyte 
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Concentration-dependence  of inhibition of chemotaxis by pertussis toxin. Chem- 
otactic migration of 21  ±  5, 25 ±  8, and 20 ±  4 net PMNL per hpf was elicited from control 
leukocytes by 3 nM LTB4 (Q), 100 nM fMLP (.), and a  1/20 dilution of C5fr (&), respectively. 
The stimulated response from pertussis toxin-treated PMNL is expressed as a percentage of 
the response obtained from control PMNL. Each data point is the mean + SD of three or four 
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Concentration-dependence of inhibition of fl-glucuronidase release by pertussis 
toxin. Control PMNL released 18.5  _  9.7%, 40.8 __+  18.0%, 22.0 +  9.6%, and 66.7 +  13.7% 
of the total/3-glucuronidase activity in response to 3 nM LTB4 (O), 1 #M fMLP (ll), 10 ng/ml 
PMA (O), and 2 uM A23187 (I-I), respectively, in the presence of 5/~g/ml of cytochalasin B. 
The stimulated response from pertussis toxin-treated PMNL is expressed as a percentage of 
the response obtained from control  PMNL.  Each  data  point  is  the  mean  +_  SD  of four 
experiments. 
TABLE  I 
Binding of LTB4 to PMNL Treated With and Without Pertussis Toxin 
Treatment 
High-affinity receptors  Low-affinity receptors 
Kd (×  10 -l°)  Receptors/PMNL  Kd (×  10 -7)  Receptors/PMNL 
M  M 
Control  9.6 -  4.9  9,900 +  3,100  3.5 _+ 2.6  440,000 +  190,000 
Pertussis toxin  3.3 +  2.9  3,900 +  900  2.0 +  0.7  440,000 +_ 200,000 
P  0.061  0.026  0.27  0.47 
PMNL  were incubated without (control) or  with  100  ng/ml  pertussis toxin  for 2  h.  The 
binding of [3HILTB4  was then assessed at 0°C. The binding parameters represent the mean 
_  SD obtained from three experiments. The P values were determined by a paired sample t- 
test. 
membranes. Homogenates prepared from control PMNL incorporated 2.2 pm 
of ADP-ribose per milligram of protein, while homogenates of PMNL treated 
with  100  ng/ml  of pertussis  toxin  incorporated  0.9  pm  of ADP-ribose  per 
milligram of protein. Preincubation of PMNL with 300 ng/ml of pertussis toxin 
for 3  h  did not further reduce the amount of [32p]-Iabeled  ADP-ribose subse- 
quently incorporated into the homogenate. Increasing the amount of NAD in 
the reaction mixture and adding a  second aliquot  of [32p]NAD  15  min  after 
initiating the ADP-ribosylation incubation did not increase the amount of ADP- 
ribose incorporated; this suggested that the incubation conditions caused com- 
plete ADP-ribosylation  of the  41  kD  protein.  Thus,  only 59%  of the  41  kD GOLDMAN  ET AL.  151 
FIGURE 4.  Pertussis toxin-catalyzed ADP-ribosylation of proteins of homogenates of PMNL. 
PMNL were incubated without (A) or with (B) 100 ng/ml pertussis toxin for 2 h. Homogenates 
~repared  from treated  PMNL were incubated  with activated pertussis  toxin and  10 #M  a- 
[  P]NAD, and the ADP-ribosylated proteins were analyzed on SDS-PAGE. 
proteins  in  PMNL  homogenates are  accessible  for  pertussis  toxin-stimulated 
ADP-ribosylation  in  intact  PMNL.  Pertussis  toxin-catalyzed  modification  of 
these accessible sites is associated with inhibition of stimulated PMNL function. 
Discussion 
The  possible  involvement of a  guanine  nucleotide-binding protein  in  the 
signal transduction process initiated by occupancy of chemotactic factor receptors 
in PMNL (15,  16),  combined with the inhibition by pertussis toxin of calcium- 
dependent release of histamine in mast cells (23), suggested that pertussis toxin 
may inhibit the increase in [Ca+2]in stimulated by chemotactic factors in human 
PMNL. The use of Quin 2 to measure [Ca+2]in permitted a direct demonstration 
of the inhibitory effects of pertussis toxin on chemotactic factor-induced stimu- 
lation of [Ca+2]in (Fig.  1). The increase in [Ca+2]i n induced by LTB4 and fMLP in 
PMNL consists of two components, an increased influx of extracellular calcium, 
and calcium release from intracellular stores (11,  12).  Human PMNL incubated 
in calcium-free media containing 5 mM EGTA will respond to LTB4 and fMLP 
with an increase in Quin 2  fluorescence, but the increase is only 10%-15%  of 
that observed in the presence of extracellular calcium (D. W. Goldman, unpub- 
lished observation), suggesting that the inhibition of Quin 2 fluorescence changes 
are in part due to the inhibition of calcium influx.  Recent studies have shown 
that the influx of 45Ca+2 induced by fMLP in guinea pig neutrophils (42) and the 
changes in [Ca+2]in induced by fMLP and  LTB4 in rabbit neutrophils (43) are 
inhibited by pertussis toxin. 152  INHIBITION  OF  PMNL  FUNCTION  BY  PERTUSSIS  TOXIN 
Pertussis toxin inhibited chemotactic factor-induced [Ca+~]in increases, chem- 
otaxis, and lysosomal enzyme release, but not non-receptor-stimulated enzyme 
release (Figs.  2 and 3), demonstrating that pertussis toxin acts at an early stage 
in the signal transduction process. The decrease in high-affinity LTB4 receptor 
number induced by pertussis toxin (Table I) implies a  direct link between the 
site of pertussis toxin action and the LTB4 receptor. Guanine nucleotides also 
decrease the number of high-affinity fMLP (15) and  LTB4  (D.  W.  Goldman, 
unpublished observation) receptors on PMNL plasma membranes. That pertussis 
toxin  may modify a  guanine  nucleotide-binding protein  is  suggested  by  the 
similar effects of guanine nucleotides and pertussis toxin on chemotactic factor 
receptors and on  a2  adrenergic receptors.  In neuroblastoma x  glioma hybrid 
cell membranes (44) and in  rat renal cortical  membranes (45),  a2 adrenergic 
receptor affinity for agonist binding is decreased, consistent with a redistribution 
of receptors between high- and  low-affinity states.  Pertussis  toxin  attenuated 
agonist-induced inhibition of adenylate cyclase, with a concomitant decrease in 
average affinity of agonist binding of ee2 adrenergic receptors. 
Reagents that increase cAMP levels in PMNL inhibit chemotaxis and lysosomal 
enzyme release (46). Pertussis toxin-catalyzed ADP-ribosylation of the a subunit 
of Gi uncouples adenylate cyclase from inhibition by 0~2 adrenergic agonists (18, 
19, 21, 44), with a resultant enhancement of cAMP levels in response to agonists 
that stimulate adenylate cyclase. However, pertussis toxin had no effect on cAMP 
levels in mast cells (22), and has been recently reported not to alter cAMP levels 
(42) or to substantially modify the fMLP-induced cAMP rise (47) in guinea pig 
neutrophils. This suggests that the inhibitory effects of pertussis toxin on PMNL 
function are not secondary to a change in cAMP content. 
A  41  kD protein,  which comigrated with  the oe subunit of Gi from human 
erythrocyte membranes on SDS-PAGE, was ADP-ribosylated by pertussis toxin 
in PMNL homogenates (Fig. 4).  Although only 59%  of the total sites available 
for ADP-ribosylation in the homogenates were accessible in intact PMNL, PMNL 
function was almost completely inhibited.  Several studies (48)  have identified 
subpopulations  of PMNL  that  are  functionally nonresponsive  to  chemotactic 
factors. If the 41  kD protein were accessible for ADP-ribosylation by pertussis 
toxin only in responding PMNL, then ADP-ribosylation of only a fraction of the 
total  sites  detected  in  homogenates  could  account  for  the  almost  complete 
inhibition  of PMNL  function.  In  that  case,  the defect in  the  nonresponding 
PMNL subpopulation might be caused by uncoupling of the 41 kD protein from 
the chemotactic factor receptors; the uncoupling phenomenon could reflect the 
same biochemical defect that makes the protein inaccessible to pertussis toxin in 
intact PMNL.  Alternatively, all the PMNL may be sensitive to pertussis toxin, 
but  a  fraction  of the  41  kD  protein  may be  sequestered  in  an  intracellular 
compartment that is not accessible to pertussis toxin, or is not involved in  the 
signal transduction process. 
Summary 
Chemotactic factors stimulate a rapid increase in the cytosolic concentration 
of intracellular calcium ions ([Ca2+]in) in human polymorphonuclear leukocytes 
(PMNL), which may be an event that is critical to the expression of chemotaxis GOLDMAN ET AL.  153 
and other PMNL functions. Treatment of PMNL with pertussis toxin catalyzes 
ADP-ribosylation of a  protein  similar or identical to  the  inhibiting regulatory 
protein of adenylate cyclase, Gi, and suppresses  the increase in [Ca2+]in elicited 
by leukotriene B4 (LTB4) and formyl-methionyMeucyl-phenylalanine.  Chemotac- 
tic migration and lysosomal enzyme release elicited by chemotactic factors were 
inhibited by pertussis toxin with a concentration-dependence similar to that for 
inhibition  of the  increase  in  [Cae+]in,  without  an  effect on  lysosomal enzyme 
release induced by the ionophore A23187  and phorbol myristate acetate. Acti- 
vated pertussis toxin catalyzed the [3zP]ADP-ribosylation of a  41  kD protein in 
homogenates of PMNL. The extent of [32P]ADP-ribosylation of this protein was 
reduced  59%  by pretreatment  of intact  PMNL  with pertussis  toxin.  Pertussis 
toxin selectively decreased the number of high-affinity receptors  for LTB4 on 
PMNL by 60%  without altering the number or binding properties  of the low- 
affinity subset of receptors.  Pertussis toxin modification of a membrane protein 
of PMNL analogous to Gi thus simultaneously alters chemotactic receptors and 
attenuates the changes in cytosolic calcium concentration and PMNL function 
caused by chemotactic factors. 
Received for publication  7January 1985 and in revised form 27 March 1985. 
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